Announcements - OBI Pharma 台灣浩鼎

2016.Jun.15

The company was invited to participate in the overseas NDR (Non-Deal Roadshow) organized by Credit Suisse, and reported the study results presented in the 2016 ASCO.

2016.Jun.14

OBI Pharma, Inc. will attend Cathay Securities' Conference on June 16th

2016.Jun.07

To correct the company’s Investor Conference presentation content on June 5 2016

2016.Jun.06

To clarify the media report

2016.Jun.05

The company will publish the clinical study data of the innovation research of OBI-822/OBI-821 for metastatic breast cancer patients at the annual meeting of 2016 ASCO.

2016.May.30

Announcement of the Company holding investor presentation and Significant post press conference

2016.May.30

Company will hold the Investor Conference

2016.May.29

The company states the media’s reports on the related matters of American Society of Clinical Oncology (ASCO).

2016.May.26

Media reports that Michael Chang, the chairman of the company, Amy Huang, the general manager and the staffs, six people in total, were guaranteed pending summons for alleged insider trading.

2016.May.19

Publication of the Breast Cancer Study Abstract to be presented at ASCO 2016

News

Latest News

Events

Latest events